Tests LIV001 for safety in people with mild-to-moderate active ulcerative colitis
Tests whether LIV001 is safe for adults with mild-to-moderate active ulcerative colitis.
Plain-language title generated from the registry record
Registry title: A Randomized, Double-Blind, Placebo Controlled, Multi - Center, Phase 1b Study to Evaluate the Safety and Tolerability of LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis
Key facts
- Where
- Rzeszow, Warsaw, and Wroclaw, PolandSee the 3 sites
- Phase
- Phase 1
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with mild-to-moderate active ulcerative colitis to test the safety and tolerability of LIV001 against a placebo.
- Age
- 18 to 64 years
- Sex
- Men and women can join.
- Disease stage
- Mild-to-moderate active ulcerative colitis.
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Poland
- Centrum Medyczne Medyk Sp. z o.o.Rzeszow, PolandNot yet recruiting
- Provita Poliklinika sp. z o.oWarsaw, PolandNot yet recruiting
- Centrum Badań Klinicznych Piotr Napora Lekarze Sp. p.Wroclaw, PolandNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorTrial details
- Who runs it
- Medytox Inc.
- Trial code
- EU 2024-514520-16-00
- Record updated
- 10 August 2026